Infection Control Related News
Prior infection and vaccines protect against Omicron Covid variant
One of the earliest studies to date of the Omicron Covid variant has revealed that previous COVID-19 infection and vaccinations offer some protection against...
Body fat stores may help to combat bacterial infections
A novel study has suggested that a person’s body fat stores play a crucial role in fighting bacterial infections.
Research carried out by scientists at...
Disease outbreaks accurately forecasted by early warning signs
New research emerging from the UK has signified that future disease outbreaks can potentially be predicted by analysing early warning signs.
A study led by...
Groundbreaking chewing gum potentially mitigates Covid transmission
A new study has revealed that an innovative chewing gum may be effective at reducing Covid transmission, providing a new weapon for curbing the...
US researchers collaborate to combat deadly Clostridium difficile superbug
A team of US biologists have conducted a novel study to attain unprecedented insights into Clostridium difficile, an incredibly virulent superbug that’s claims thousands...
New covid treatment cuts hospitalisation and death by 79%
The UK regulator, Medicines and Healthcare products Regulatory Agency (MHRA), has authorised Xevudy (sotrovimab) as a covid treatment for people at high risk of...
First new covid variant cases found in UK
Following overnight genome sequencing, the UK Health Security Agency (UKHSA) has confirmed three cases of the new covid variant, Omicron (B.1.1.529), in the UK...
Omicron named a SARS-CoV-2 variant of concern by WHO
The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE), independent experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assess mutations and...
Antibiotic-resistant infections have fallen for the first time since 2016
New data by the UK Health Security Agency (UKHSA) shows that antibiotic-resistant bloodstream infections fell in 2020, from 65,583 in 2019 to 55,384. However,...
Risk of COVID-19 infection steadily increases after second vaccine dose
A research team based in Israel has identified that the risk of infection from COVID-19 gradually increases after receiving a second vaccine dose.
Research emerging...
COVID-19 demonstrates the ability to infect an unborn baby
Researchers have identified that an unborn baby can potentially contract COVID-19 infection, uncovering the mechanism behind catching the virus.
A study, led by researchers from...
Ensuring safe health products with United States Pharmacopeia testing
Microbiological testing specialists Nova Biologicals dissect how United States Pharmacopoeia testing protocols help ensure that medical devices and pharmaceuticals meet the optimal standards for...
Scientists say plant-derived drug is effective in blocking SARS-CoV-2 Delta variant
A recent discovery by scientists at the University of Nottingham has found that a plant-based antiviral treatment is effective at treating all variants of...
Combatting Crimean-Congo haemorrhagic fever with COVID technology
A scientific research consortium called Prometheus is employing the same framework used to develop COVID-19 vaccines to tackle Crimean-Congo haemorrhagic fever.
Crimean-Congo haemorrhagic fever (CCHF)...
SSRI antidepressants observed to protect COVID-19 patients from death
Novel research from the US has identified that SSRI antidepressants may possess qualities that help to reduce deaths in COVID-19 patients.
In a study conducted...
Investigating the impacts of COVID-19 variants on dialysis treatment
A team of international researchers has examined the efficacy of COVID-19 vaccines for patients undergoing dialysis treatment.
The study, led by experts at the Marien...
Ebola vaccine by University of Oxford to begin human trials
The University of Oxford has begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers against Zaire and Sudan...
Licensing agreed by University of Birmingham for COVID nasal spray
The University of Birmingham has signed a licensing agreement with Birmingham Biotech Ltd to commercialise an anti-viral COVID nasal spray that can offer protection...
US approves vaccine for COVID-19 in children over five
The US has recommended that children aged five to 11 be vaccinated against COVID-19 with the Pfizer-BioNTech vaccine, allowing providers to begin the vaccination...
Pfizer/BioNTech booster vaccine reduces COVID-19 hospitalisations
In the most extensive real-world study to date, an international research team has identified that the Pfizer/BioNTech booster vaccine is highly effective at reducing...